RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: To investigate the diagnostic and prognostic significance of the blood-count derived systemic immunoinflammatory parameters in patients with thyroid-associated ophthalmopathy (TAO). Methods: In this retrospective case-control study, the blood-count parameters and neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio, and systemic immune-inflammatory index (SII), thyroid peroxidase antibody, and anti-thyroglobulin antibody were evaluated in 46 patients with TAO and 46 matched controls. The associations of the immunoinflammatory parameters with clinical outcomes were analyzed among TAO patients. Results: Significant differences were found in NLR, PLR, SII, and lymphocyte count between the controls and the TAO group (p < 0.05 for all). In logistic regression analysis, these inflammatory parameters did not have any prognostic effect on the clinical outcomes of the TAO (p > 0.05 for all). The patients, who needed systemic treatment due to any ocular involvement of TAO during the follow-up period, had significantly lower platelet count (p = 0.001) and PLR (p = 0.02) at the time of initial diagnosis when compared to the no treatment-needed group of the TAO patients. The initial platelet count was significantly associated with the subsequent steroid need due to TAO during the follow-up period (β = -0.02, p = 0.03). Conclusions: NLR, PLR, and SII may serve as potential inflammatory markers in the identification of the TAO, although they have no evident prognostic significance in TAO. However, the relatively lower platelet count at initial diagnosis may be associated with the need for systemic therapy during the follow-up in patients with TAO.

번역하기

목차 (Table of Contents)

Materials and Methods Results Discussion Conflict of Interest References

Materials and Methods Results Discussion Conflict of Interest References

참고문헌 (Reference)

1 Lhotta K, "Treatment of concurrent thrombotic thrombocytopenic purpura and Graves’disease: a report on two cases" 2018 : 5747969-, 2018

2 Yamada M, "Thyroid-associated ophthalmopathy:clinical features, pathogenesis, and management" 37 : 523-549, 2000

3 Kurata Y, "Thrombocytopenia in Graves’ disease: effect of T3 on platelet kinetics" 63 : 185-190, 1980

4 Tabarkiewicz J, "The role of IL-17 and Th17 lymphocytes in autoimmune diseases" 63 : 435-449, 2015

5 Van der Weerd K, "The peripheral blood compartment in patients with Graves’ disease:activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes" 174 : 256-264, 2013

6 Tomczynska M, "The mutual cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases" 65 : 17-24, 2018

7 Armen Yuri Gasparyan, "The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases" 대한진단검사의학회 39 (39): 345-357, 2019

8 Hu B, "Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma" 20 : 6212-6222, 2014

9 Jomrich G, "Systemic Immune-Inflammation Index (SII) predicts poor survival in pancreatic cancer patients undergoing resection" 24 : 610-618, 2020

10 Huang J, "Systemic Immune- Inflammatory Index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention" 25 : 9690-9701, 2019